Abpro Holdings (NASDAQ: ABP) hit with Nasdaq delisting, eyes OTC Pink trading
Rhea-AI Filing Summary
Abpro Holdings, Inc. reported that Nasdaq’s Hearings Panel has decided to delist its common stock and public warrants because the company did not meet the minimum equity requirement under Nasdaq Listing Rule 5550(b)(1) by February 16, 2026. Trading on Nasdaq is scheduled to be suspended at the open on February 23, 2026.
The company has 15 days from February 18, 2026 to request a review by the Nasdaq Listing and Hearing Review Council and expects to appeal. If no appeal is pursued or successful, Nasdaq is expected to file a Form 25 to delist and deregister the securities under Section 12(b).
After Nasdaq trading is suspended, Abpro expects its common stock and public warrants to be eligible for quotation on the OTC Pink Market under the symbols “ABP” and “ABPWW.” The company warns investors that OTC Pink trading may involve reduced information, lower liquidity, and greater price volatility, and it cannot assure that any broker-dealer will make a market in its securities.
Positive
- None.
Negative
- Nasdaq delisting and trading suspension: Abpro did not meet Nasdaq’s minimum equity standard under Rule 5550(b)(1), and its securities are scheduled for trading suspension on Nasdaq on February 23, 2026, with a potential move to the OTC Pink Market and increased volatility and liquidity risk.
Insights
Nasdaq delisting shifts Abpro to OTC Pink with higher trading risk.
The decision by the Nasdaq Hearings Panel to delist Abpro Holdings follows the company’s failure to satisfy the minimum equity requirement in Listing Rule 5550(b)(1) by February 16, 2026. Trading suspension on Nasdaq is scheduled for the open on February 23, 2026, which moves the stock off a major exchange.
Abpro plans to appeal within the 15‑day window from February 18, 2026, but the outcome is uncertain. If the decision stands, Nasdaq is expected to file a Form 25 to delist and deregister the securities under Section 12(b), formally ending Nasdaq listing status.
The company expects quotation on the OTC Pink Market under “ABP” and “ABPWW,” but explicitly notes potential limited information availability, reduced transparency and liquidity, and greater volatility. Actual trading activity will depend on whether broker‑dealers choose to make a market after the Nasdaq suspension.
8-K Event Classification
FAQ
What did Abpro Holdings, Inc. (ABP) announce regarding its Nasdaq listing?
When will Abpro Holdings (ABP) trading be suspended on Nasdaq?
Can Abpro Holdings (ABP) appeal the Nasdaq delisting decision?
Where will Abpro Holdings (ABP) trade after Nasdaq suspends its securities?
What is the significance of Nasdaq Listing Rule 5550(b)(1) for Abpro (ABP)?
What happens if Abpro (ABP) does not successfully appeal the Nasdaq decision?
AI-generated analysis. How Rhea-AI works. Not financial advice.